Background: The biosafety of gene therapy products remains a major challenge to their introduction into the clinic. In particular, the problem of immunogenicity of viral vectors is the focus of attention. Large animals such as pigs, whose anatomical and physiological characteristics are similar to those of humans, have an advantage in testing vector systems.
View Article and Find Full Text PDFProbl Sotsialnoi Gig Zdravookhranenniiai Istor Med
May 2024
The article considers results of study of the R&D sector directions development in system of Russian medical higher education in the context of digitization. The analysis made it possible to substantiate timeliness and importance of solving problems of improving medical services quality against the background of necessity for medical workers to systematically master breakthrough digital technologies in current medical practice. This conditions importance to ensure efficiency of R&D in Russian higher medical education in the context of digitization.
View Article and Find Full Text PDFImmunotherapy in oncologic diseases involves the use of drugs which stimulate the immune system and indirectly suppress tumor cells growth. These agents have expanded the treatment options for cancer patients. Despite the impressive success achieved in the development of immune checkpoint inhibitors (ICIs) and subsequent approval in a broader spectrum of malignant tumors, most patients are not responded the therapy.
View Article and Find Full Text PDFThe possibility of pigment detection and recognition in different environments such as solvents or proteins is a challenging, and at the same time demanding, task. It may be needed in very different situations: from the nondestructive in situ identification of pigments in paintings to the early detection of fungal infection in major agro-industrial crops and products. So, we propose a prototype method, the key feature of which is a procedure analyzing the lineshape of a spectrum.
View Article and Find Full Text PDFIntroduction: Renal cancer ranks 10 in the mortality structure of the Russian Federation. The introduction of checkpoint inhibitors has changed the paradigm of treatment of patients with malignant neoplasms.
Method: Data from clinical trials have shown good progression-free median and median overall survival.